A Systemic Prime–Intrarectal Pull Strategy Raises Rectum-Resident CD8+ T Cells for Effective Protection in a Murine Model of LM-OVA Infection-Reference-Cited by-同舟云学术

A Systemic Prime–Intrarectal Pull Strategy Raises Rectum-Resident CD8+ T Cells for Effective Protection in a Murine Model of LM-OVA Infection

Published:2020-09-24 Issue: Volume:11 Page:
ISSN:1664-3224
Container-title:Frontiers in Immunology
language:
Short-container-title:Front. Immunol.

Author:

He Qian,Jiang Lang,Cao Kangli,Zhang Linxia,Xie Xinci,Zhang Shuye,Ding Xiangqing,He Yongquan,Zhang Miaomiao,Qiu Tianyi,Jin Xuanxuan,Zhao Chen,Zhang Xiaoyan,Xu Jianqing

Funder

National Natural Science Foundation of China

National Basic Research Program of China

Publisher

Frontiers Media SA

Subject

Immunology,Immunology and Allergy

Reference47 articles.

1. Guarding the perimeter: protection of the mucosa by tissue-resident memory T cells;Cauley;Mucosal Immunol.,2013

2. Efficacy assessment of a cell-mediated immunity HIV-1 vaccine (the Step Study): a double-blind, randomised, placebo-controlled, test-of-concept trial;Buchbinder;Lancet.,2008

3. Safety and efficacy of the HVTN 503/Phambili Study of a clade-B-based HIV-1 vaccine in South Africa: a double-blind, randomised, placebo-controlled test-of-concept phase 2b study;Gray;Lancet Infect Dis.,2011

4. Lessons from the RV144 thai phase III HIV-1 vaccine trial and the search for correlates of protection;Kim;Annu Rev Med.,2015

5. CD8+ T-lymphocyte response to major immunodominant epitopes after vaginal exposure to simian immunodeficiency virus: too late and too little;Reynolds;J Virol.,2005

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Bridging the gaps to overcome major hurdles in the development of next-generation tuberculosis vaccines;Frontiers in Immunology;2023-08-11

2. Preclinical evaluation of safety and immunogenicity of a primary series intranasal COVID-19 vaccine candidate (BBV154) and humoral immunogenicity evaluation of a heterologous prime-boost strategy with COVAXIN (BBV152);Frontiers in Immunology;2022-12-08

3. Preclinical evaluation of safety and immunogenicity of a primary series intranasal COVID-19 vaccine candidate (BBV154), and humoral immunogenicity evaluation of a heterologous prime-boost strategy with COVAXIN (BBV152);2022-09-13

4. Prompt Antiviral Action of Pulmonary CD8+ TRM Cells Is Mediated by Rapid IFN-γ Induction and Its Downstream ISGs in the Lung;Frontiers in Immunology;2022-02-22

5. Combinatorial Viral Vector-Based and Live Attenuated Vaccines without an Adjuvant to Generate Broader Immune Responses to Effectively Combat Pneumonic Plague;mBio;2021-12-21